TSM vs. BBIO
TSM (Taiwan Semiconductor Manufacturing Company Limited) and BBIO (BridgeBio Pharma, Inc.) are both stocks. TSM operates in Semiconductors (Technology), while BBIO operates in Biotechnology (Healthcare). Over the past 5 years, TSM returned 31.67%/yr vs 1.89%/yr for BBIO. At a 0.25 correlation, their price movements are largely independent.
Performance
TSM vs. BBIO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, TSM achieves a 40.84% return, which is significantly higher than BBIO's -11.92% return.
TSM
- 1D
- 2.80%
- 1M
- 3.67%
- YTD
- 40.84%
- 6M
- 42.15%
- 1Y
- 110.53%
- 3Y*
- 63.10%
- 5Y*
- 31.67%
- 10Y*
- 35.71%
BBIO
- 1D
- -0.35%
- 1M
- -0.03%
- YTD
- -11.92%
- 6M
- -9.25%
- 1Y
- 74.44%
- 3Y*
- 61.48%
- 5Y*
- 1.89%
- 10Y*
- —
TSM vs. BBIO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
TSM Taiwan Semiconductor Manufacturing Company Limited | 40.84% | 55.91% | 92.58% | 42.33% | -36.75% | 12.09% | 92.67% | 48.85% |
BBIO BridgeBio Pharma, Inc. | -11.92% | 178.75% | -32.03% | 429.79% | -54.32% | -76.54% | 102.88% | 27.22% |
Correlation
The correlation between TSM and BBIO is 0.24, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.24 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.22 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.26 |
Correlation (All Time) Calculated using the full available price history since Jun 28, 2019 | 0.25 |
Fundamentals
TSM:
$2.21T
BBIO:
$13.12B
TSM:
$373.98
BBIO:
-$3.76
TSM:
0.54
BBIO:
23.00
TSM:
$4.13T
BBIO:
$566.04M
TSM:
$2.55T
BBIO:
$538.20M
TSM:
$3.14T
BBIO:
-$602.24M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
TSM vs. BBIO — Risk / Return Rank
TSM
BBIO
TSM vs. BBIO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Taiwan Semiconductor Manufacturing Company Limited (TSM) and BridgeBio Pharma, Inc. (BBIO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| TSM | BBIO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.46 | ||
| Sortino ratioReturn per unit of downside risk | +1.35 | ||
| Omega ratioGain probability vs. loss probability | 1.44 | 1.30 | +0.14 |
| Calmar ratioReturn relative to maximum drawdown | 6.13 | 3.70 | +2.43 |
| Martin ratioReturn relative to average drawdown | 21.94 | 9.25 | +12.69 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| TSM | BBIO | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 3.06 | 1.60 | +1.46 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.85 | 0.02 | +0.83 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 1.05 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.37 | 0.16 | +0.20 |
Drawdowns
TSM vs. BBIO - Drawdown Comparison
The maximum TSM drawdown since its inception was -89.08%, roughly equal to the maximum BBIO drawdown of -92.80%. Use the drawdown chart below to compare losses from any high point for TSM and BBIO.
Loading charts...
Drawdown Indicators
| TSM | BBIO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -89.08% | -92.80% | +3.72% |
Max Drawdown (1Y)Largest decline over 1 year | -18.14% | -20.25% | +2.11% |
Max Drawdown (3Y)Largest decline over 3 years | -36.82% | -49.08% | +12.26% |
Max Drawdown (5Y)Largest decline over 5 years | -56.47% | -91.89% | +35.42% |
Max Drawdown (10Y)Largest decline over 10 years | -56.47% | — | — |
Current DrawdownCurrent decline from peak | -4.45% | -15.69% | +11.24% |
Average DrawdownAverage peak-to-trough decline | -42.87% | -45.80% | +2.93% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.06% | 8.07% | -3.01% |
Volatility
TSM vs. BBIO - Volatility Comparison
Taiwan Semiconductor Manufacturing Company Limited (TSM) and BridgeBio Pharma, Inc. (BBIO) have volatilities of 12.47% and 12.10%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| TSM | BBIO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 12.47% | 12.10% | +0.37% |
Volatility (6M)Calculated over the trailing 6-month period | 28.23% | 34.41% | -6.18% |
Volatility (1Y)Calculated over the trailing 1-year period | 36.40% | 46.75% | -10.35% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 37.40% | 85.95% | -48.55% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 34.20% | 83.80% | -49.60% |
Dividends
TSM vs. BBIO - Dividend Comparison
TSM's dividend yield for the trailing twelve months is around 0.78%, while BBIO has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BBIO BridgeBio Pharma, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
TSM Taiwan Semiconductor Manufacturing Company Limited | 0.78% | 1.00% | 1.18% | 1.78% | 2.49% | 1.57% | 1.56% | 3.46% | 3.64% | 2.32% | 2.61% | 2.54% |
Financials
TSM vs. BBIO - Financials Comparison
This section allows you to compare key financial metrics between Taiwan Semiconductor Manufacturing Company Limited and BridgeBio Pharma, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
TSM vs. BBIO - Profitability Comparison
TSM - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Taiwan Semiconductor Manufacturing Company Limited reported a gross profit of 759.06B and revenue of 1.15T. Therefore, the gross margin over that period was 66.3%.
BBIO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, BridgeBio Pharma, Inc. reported a gross profit of 178.39M and revenue of 180.60M. Therefore, the gross margin over that period was 98.8%.
TSM - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Taiwan Semiconductor Manufacturing Company Limited reported an operating income of 664.08B and revenue of 1.15T, resulting in an operating margin of 58.0%.
BBIO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, BridgeBio Pharma, Inc. reported an operating income of -105.96M and revenue of 180.60M, resulting in an operating margin of -58.7%.
TSM - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Taiwan Semiconductor Manufacturing Company Limited reported a net income of 578.40B and revenue of 1.15T, resulting in a net margin of 50.5%.
BBIO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, BridgeBio Pharma, Inc. reported a net income of -164.04M and revenue of 180.60M, resulting in a net margin of -90.8%.
Frequently Asked Questions
TSM and BBIO have a correlation of 0.24, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
TSM has higher volatility (12.47%) compared to BBIO (12.10%). In terms of maximum drawdown, TSM dropped -89.08% vs BBIO's -92.80%.
TSM currently has the higher Sharpe Ratio (3.06 vs 1.60), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for TSM and BBIO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer